This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rosenblatt, J E Articles by Sloan, L M Search for Related Content PubMed PubMed Citation Articles by Rosenblatt, J E Articles by Sloan, L M

Evaluation of an enzyme-linked immunosorbent assay for detection of Cryptosporidium spp. in stool specimens.

Division of Clinical Microbiology, Mayo Clinic, Rochester, Minnesota 55905.

ABSTRACT

We evaluated a commercially produced enzyme-linked immunosorbent assay (ELISA; LMD Laboratories, Inc.) for the detection of Cryptosporidium spp. in 296 stool specimens submitted to the Mayo Clinic parasitology laboratory for routine examination. The specimens examined were fresh (4 specimens), were stored frozen at -65 degrees C (49 specimens), or were preserved in 10% formalin (243 specimens). Results were compared with those obtained by indirect immunofluorescent antibody detection (Merifluor Cryptosporidium/Giardia; Meridian Diagnostics, Inc.). One hundred of the specimens were positive by indirect immunofluorescent antibody and ELISA, while 187 were negative by both methods; 91 of these negative stool samples contained 121 parasites of 17 different species. Eight ELISA false negatives and one false positive were observed. The ELISA sensitivity was 93%, specificity was 99%, and the positive predictive value was 99%. Storage of specimens preserved in 10% formalin or frozen fresh at -65 degrees C for up to 18 months did not appear to affect the results. There was no cross-reactivity with Giardia lamblia (54 negative specimens) or with the 16 other parasites present in the ELISA-negative stool samples. The ELISA is a fast, easy-to-read, and accurate method for the detection of Cryptosporidium spp. in stool specimens.

This article has been cited by other articles:

• Johnston, S. P., Ballard, M. M., Beach, M. J., Causer, L., Wilkins, P. P. (2003). Evaluation of Three Commercial Assays for Detection of Giardia and Cryptosporidium Organisms in Fecal Specimens. J. Clin. Microbiol. 41: 623-626 [Abstract] [Full Text]  
• Garcia, L. S., Shimizu, R. Y., Novak, S., Carroll, M., Chan, F. (2003). Commercial Assay for Detection of Giardia lamblia and Cryptosporidium parvum Antigens in Human Fecal Specimens by Rapid Solid-Phase Qualitative Immunochromatography. J. Clin. Microbiol. 41: 209-212 [Abstract] [Full Text]  
• Katanik, M. T., Schneider, S. K., Rosenblatt, J. E., Hall, G. S., Procop, G. W. (2001). Evaluation of ColorPAC Giardia/Cryptosporidium Rapid Assay and ProSpecT Giardia/Cryptosporidium Microplate Assay for Detection of Giardia and Cryptosporidium in Fecal Specimens. J. Clin. Microbiol. 39: 4523-4525 [Abstract] [Full Text]  
• Garcia, L. S., Shimizu, R. Y., Bernard, C. N. (2000). Detection of Giardia lamblia, Entamoeba histolytica/Entamoeba dispar, and Cryptosporidium parvum Antigens in Human Fecal Specimens Using the Triage Parasite Panel Enzyme Immunoassay. J. Clin. Microbiol. 38: 3337-3340 [Abstract] [Full Text]  
• Garcia, L. S., Shimizu, R. Y. (2000). Detection of Giardia lamblia and Cryptosporidium parvum Antigens in Human Fecal Specimens Using the ColorPAC Combination Rapid Solid-Phase Qualitative Immunochromatographic Assay. J. Clin. Microbiol. 38: 1267-1268 [Abstract] [Full Text]